I find it interesting that The Eversull Group has become a scapegoat. I am not defending anything, however, that his Group has done or failed to do. I haven't been sure what to expect from the Group given what the Group was handed with which to work. We surely don't know enough at this point. So...I guess my question is: Is the Eversull Group responsible for the current information, trading and price malaise or are these phenomena more directly related to Medizone's shortcomings at FIME? Management could be quite pleased that fingers are being pointed in a different direction right now. Public relations groups always can be replaced when their current contracts run out.

Everyone on this board, MSTR, has bought products where the actual patents were "pending". This product is no different. What actually can be patented here? Ozone cannot be patented, hydrogen peroxide cannot be patented. The plastics, fiberglass, etc. for the casing cannot be patented. A "use" patent, however, can be applied to the procedure. Taking pictures of a casing would be no big risk at all. Remember that if Medizone can't get a use patent, neither can anyone else. Medizone was there first. There should have been a workable model with demo capabilities at a gathering of peers as powerful as FIME. One needs to look no farther than the interest in the stock over the last five days for justification. This message board is doing great work coming up with unique marketing ideas for the various potential applications. My fear is that you all still will be bouncing around these ideas one to two years from now. The greatest challenge a new business faces is successfully transforming itself from a research organization to a marketing organization. So much background work in so many areas has to be done prior to actual marketing....and then there's manufacturing. My posts have been successful in effecting a bit of a "circling of the wagons" around current management. I hope you guys are right.

How many of you on this board would be "gone" forever if some bit of news ran Medizone stock up to 60 cents? How many of you would be eager to have the Marshall family sell the company for.....say..... a buck and a half a share once the use patents are approved? In essence, I am asking how many of you don't really care about the company's product capabilities but merely want to make a decent profit on this wild speculation? A large percentage of mere speculators would justify the reluctance of shareholders to hold the company's feet to the fire on market research. What is this company really worth? How many different markets are applicable to AscepticSure? Production capabilities? When can revenue and gross profit streams be identified within the specific industries?
Potential suitors will figure it out if the company won't, and any price offered certainly will be a low-ball effort from one of those big boys. IMHO, that scenario would be a real shame. I would like to see this company, that has a long history of non-accomplishment (not all its own fault), hit a grand-slam for shareholders who care and, more importantly, for the public who really needs the products. Major attitude adjustments are going to be needed, however, to make that happen.

Don't forget Gummo, Eli. True. Any comparison of details between two industries would be like comparing apples to oranges. The basic concepts, however, are the same. When one has his name on a marquis, one is expected to perform. No......there is no way Medizone should have been expected to decontaminate the entire FIME show. You know what though....since you brought it up.....the company could have contracted well in advance to have a controlled decontamination of one of the restrooms. I am happy to see cheerleaders come out and challenge some very basic marketing concepts. The psychology of this message board is quite interesting. Everyone has his/her own agenda for being here. My agenda probably differs from most of you, having followed this company for 24 years. More later.

Cheerleading vs. Substance. I also have posted twice under the name Truthsearch. I had the opportunity and was ready to attend FIME, but a young lady near and dear to my heart graduated from Marine Corps OCS at Quantico last week. So I spent five days in northern Virginia instead. Had I attended FIME, my head scratching would have become feverish. Imagine being in the home furnishings business. A builder comes to you and asks you to take part in a Parade of Homes show. What a grand opportunity to show your stuff! You have signs advertising your business on all the lawns outside the homes that you are going to furnish. Yet.....when people walk into the homes, they only see bare rooms with easels containing graphics depicting what pieces of furniture are to be used in what areas of the house and how they are to be functional. This scenario, until I can be convinced otherwise, is what occurred at FIME. I ask again: somebody, on this board, please straighten me out.

Cheerleading vs. Substance. One would believe that the company actually has a working prototype machine to conduct hospital tests. One also would believe that the company sent a real machine to Purdue to conduct bedbug studies. How much more difficult would it have been for the company to grit its teeth and assemble just one more machine for the largest trade show it may ever see? One sale sight unseen? I understand from this board that the going price for a machine is supposed to be in the neighborhood of 95k? So we see a sale at a 20%+ discount when there supposedly is no real competition in this field? Someone please straighten me out. My head scratching is going to cause baldness sometime soon.

This week it has been way to easy to buy shares underneath the ask price. There are shares for sale in the middle of the spread. I understand there are to be "boots on the ground" at FIME? One would hope that a trade show of this magnitude would entice Medizone to actually have a physcial product on hand and a graphics illustration depicting efficacy of the product and its potential uses. Anything less, I am afraid, would be most disappointing.